Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease.
Eugene HanEun Young LeeJae Seung LeeHye-Won LeeBeom Kyung KimJun Yong ParkDo Young KimSang Hoon AhnByung-Wan LeeEun Seok KangBong Soo ChaSeung-Up KimPublished in: Gut and liver (2022)
Individuals with MAFLD had a substantial ASCVD risk compared to those without MAFLD. Accompanying significant liver fibrosis further enhanced the risk of ASCVD among subjects with MAFLD.